Lijie Ma
Beijing Chao-Yang Hospital, Capital Medical University(CN)
Publications by Year
Research Areas
Dialysis and Renal Disease Management, MicroRNA in disease regulation, Blood Pressure and Hypertension Studies, RNA modifications and cancer, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma(2019)1,125 cited
- → Risk factors for mortality in patients undergoing hemodialysis: A systematic review and meta-analysis(2017)257 cited
- → Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma(2019)255 cited
- → Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non‑small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway(2019)99 cited
- → Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma(2018)90 cited
- → Resveratrol enhanced anticancer effects of cisplatin on non-small cell lung cancer cell lines by inducing mitochondrial dysfunction and cell apoptosis(2015)80 cited
- → Functional and Structural Alterations With 24-Hour Myocardial Hibernation and Recovery After Reperfusion(1996)78 cited
- → Overexpression of protein O-fucosyltransferase 1 accelerates hepatocellular carcinoma progression via the Notch signaling pathway(2016)58 cited
- → Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway(2016)57 cited
- → PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome(2020)56 cited